Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-27

Clinical Trial Update: Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study [EARLY_Phase 1]

View source ↗

Summary

An early-phase randomized, placebo-controlled study evaluating whether atomoxetine can reduce primary nocturnal enuresis in children with ADHD; the trial is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

Sponsor: Tanta University | Conditions: ADHD, Primary Nocturnal Enuresis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING